NCT04250779 Evaluating Efficacy of Smart Device in Assisting With Inhaler Technique and Adherence Status UNKNOWN Phase EARLY_PHASE1
NCT04247971 Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma Status COMPLETED Phase N/A
NCT04240522 Prospective Longitudinal Observational Research in Atopic Dermatitis Status RECRUITING Phase N/A
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04233762 Effect of Sex Hormone During the Menstrual Cycle on Capsaicin Evoked Cough Responses Status COMPLETED Phase N/A
NCT04230369 Internet-delivered CBT for Anxiety Related to Asthma Status ACTIVE_NOT_RECRUITING Phase NA
NCT04215848 As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period Status COMPLETED Phase PHASE3
NCT04212676 The Effect of Body Awareness Therapy on Postural Stability, Balance and Fear of Falling in Patients With COPD Status UNKNOWN Phase NA
NCT04207840 Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals Status COMPLETED Phase PHASE4
NCT04206761 Investigating the Effects of QVM149 on MRI Ventilation Defects Status WITHDRAWN Phase PHASE3
NCT04203797 A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma Status COMPLETED Phase PHASE4
NCT04203472 Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma Status COMPLETED Phase NA
NCT04202263 Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Status UNKNOWN Phase PHASE2
NCT04191447 Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma Status UNKNOWN Phase PHASE3
NCT04191434 Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma Status UNKNOWN Phase PHASE3
NCT04187508 A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen Status WITHDRAWN Phase PHASE2